PharmaResearch Co., Ltd. (KOSDAQ:214450)
366,000
-3,000 (-0.81%)
Sep 9, 2026, 3:30 PM KST
PharmaResearch Revenue
PharmaResearch had revenue of 178.70B KRW in the quarter ending June 30, 2026, with 27.09% growth. This brings the company's revenue in the last twelve months to 603.58B, up 34.19% year-over-year. In the year 2025, PharmaResearch had annual revenue of 536.29B with 53.18% growth.
Revenue (ttm)
603.58B
Revenue Growth
+34.19%
P/S Ratio
6.30
Revenue / Employee
1.10B
Employees
550
Market Cap
3.80T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 536.29B | 186.17B | 53.18% |
| Dec 31, 2024 | 350.12B | 89.10B | 34.14% |
| Dec 31, 2023 | 261.01B | 66.25B | 34.02% |
| Dec 31, 2022 | 194.76B | 40.68B | 26.40% |
| Dec 31, 2021 | 154.08B | 45.34B | 41.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DongKook Pharmaceutical | 979.60B |
| Huons Global | 846.78B |
| ST Pharm | 386.46B |
| Sam Chun Dang Pharm. | 259.90B |
| BINEX | 157.28B |
| Oscotec | 144.18B |
| CG Invites | 30.11B |
| Mezzion Pharma | 8.43B |